Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volasertib in Advanced Urothelial Cancer
NCT01023958Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of volasertib in urothelial carcinoma (UC), sponsored by Boehringer Ingelheim. Started Nov 2009; status: completed.
02
Drugs
volasertib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01023958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023958.